Skip to content
Hair Pipeline
← Back to the pipeline

OrganTech / Tsuji follicular primordium

OrganTech / Tsuji follicular primordium is at the preclinical stage for androgenetic alopecia, developed by OrganTech.

Japanese follicle-regeneration research aiming at lab-built follicle 'seeds'.

Monthly digest of verified phase changes. A confirmation link goes out first; unsubscribe is one click on every mail.

Developed by
OrganTech
Current phase
Preclinical

Animal data exists; the sponsor is working toward permission to test in humans.

Mechanism
Stem cell activation

Uses stem or progenitor cells to regenerate or replace follicle tissue.

Also known as
Tsuji, OrganTech, RIKEN hair
Last public activity
No trials on record
Copy last reviewed
August 2026
Record confidence
Low

A research record, not medical advice: being listed here says nothing about whether a treatment works or whether it is right for you. Talk to a dermatologist about your own case.

Development history

No phase changes recorded yet.

Registered trials

Pulled automatically from ClinicalTrials.gov. Matching is by name and development code, so occasional gaps are possible — tell us if you spot one.

No trials matched to this programme in ClinicalTrials.gov.

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first.

Sources

Related programmes

Other programmes in the register with the same mechanism: Stem cell activation.

Cite this page

Hair Pipeline, "OrganTech / Tsuji follicular primordium — development record", hairpipeline.com/pipeline/organtech-follicle-primordium